/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

GH RESEARCH PLC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$14.66 0.0235(2.35%) GHRS at 04 Dec 2025 04:33 PM Biotechnology
Lowest Today 13.99
Highest Today 14.31
Today’s Open 14.13
Prev. Close 14.05
52 Week High 20.50
52 Week Low 6.72
Day’s Range: Low 13.99 High 14.31
52-Week Range: Low 6.72 High 20.50
1 day return -
1 Week return -5.77
1 month return +6.32
3 month return +2.2
6 month return +14.59
1 year return +79.62
3 year return +20.25
5 year return -
10 year return -

Institutional Holdings

Bvf Inc 14.23

RA Capital Management, LLC 12.38

RTW INVESTMENTS, LLC 8.93

FMR Inc 8.21

Fidelity Growth Compy Commingled Pl S 4.11

Cormorant Asset Management, LLC 3.24

Deep Track Capital, LP 3.22

The Toronto-Dominion Bank 3.17

Fidelity Growth Company Fund 2.52

Jefferies Financial Group Inc 1.14

Verition Fund Managegment, LLC 1.06

5AM Venture Management, LLC 0.92

Fidelity Growth Company K6 0.90

UBS Group AG 0.74

Fidelity Series Growth Company 0.68

Fidelity Select Biotechnology 0.55

Morgan Stanley - Brokerage Accounts 0.45

Alyeska Investment Group, L.P. 0.41

Millennium Management LLC 0.33

StemPoint Capital LP 0.16

Morgan Stanley Inception 0.12

Morgan Stanley Inst Inception I 0.12

BlackRock Inc 0.10

AdvisorShares Psychedelics ETF 0.09

HighVista Strategies LLC 0.08

EQ/Morgan Stanley Small Cap Growth K 0.08

Northern Trust Corp 0.06

AdvisorShares Investments, LLC 0.06

iShares MSCI Ireland ETF 0.06

Fidelity Nasdaq Composite Index 0.06

Geode Capital Management, LLC 0.06

A4Investments SICAV SIF ACCI IlanaA2EURH 0.02

Virtus LifeSci Biotech Clinical Trls ETF 0.02

SPDR® S&P® International Small Cap ETF 0.01

Northern Small Cap Core I 0.01

NT Quality SCC US Fund - L 0.01

NT Quality Small Cap Core 0.01

Market Status

Strong Buy: 5

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 871.51 M

PB Ratio 3.2271

PE Ratio 0.0

Enterprise Value 652.44 M

Total Assets 188.27 M

Volume 215750

Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:-315000 -0.3M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-35587000 -35.6M, FY22:-7135000 -7.1M, FY21:-9211000 -9.2M, FY20:-446000 -0.4M, FY19:-310000 -0.3M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-89000 -0.1M, Q2/2025:-82000 -0.1M, Q1/2025:-76000 -0.1M, Q3/2024:null 0.0M, Q2/2024:-78000 -0.1M

Quarterly Net worth Q3/2025:-14020000 -14.0M, Q2/2025:-9289000 -9.3M, Q1/2025:-10812000 -10.8M, Q3/2024:-12114000 -12.1M, Q2/2024:-10379000 -10.4M

Fund house & investment objective

Company Information GH Research PLC, together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States. Its lead product candidate is GH001, an inhalable mebufotenin product candidate, which is in phase 2b clinical trial for treating patients with treatment-resistant depression; and in phase 2a clinical trial for treating bipolar II disorder and a current major depressive episode, as well as female patients with postpartum depression. The company also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.

Organisation Biotechnology

Employees 50

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow